Skip to main content


New targets and new strategy for the treatment of systemic autoimmune diseases

Guest edited by Yoshiya Tanaka

A thematic series in Inflammation and Regeneration.

This series of articles has not been sponsored. All articles have undergone the journal's standard peer review process overseen by the Guest Editor. The Guest Editor declares no competing interests.

  1. Review

    BAFF- and APRIL-targeted therapy in systemic autoimmune diseases

    B cells play a pivotal role in autoimmunity not only by producing pathogenic autoantibodies but also by modulating immune responses via the production of cytokines and chemokines. The B cell-activating factor/...

    Shingo Nakayamada and Yoshiya Tanaka

    Inflammation and Regeneration 2016 36:6

    Published on: 21 July 2016

  2. Review

    GM-CSF as a therapeutic target in autoimmune diseases

    Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been known as a hematopoietic growth factor and immune modulator. Recent studies revealed that GM-CSF also had pro-inflammatory functions and contr...

    Aoi Shiomi, Takashi Usui and Tsuneyo Mimori

    Inflammation and Regeneration 2016 36:8

    Published on: 5 July 2016